Alitto, Anna Rita
 Distribuzione geografica
Continente #
NA - Nord America 599
EU - Europa 490
AS - Asia 122
AF - Africa 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.217
Nazione #
US - Stati Uniti d'America 592
DE - Germania 147
SE - Svezia 119
CN - Cina 64
UA - Ucraina 61
IT - Italia 54
IN - India 34
IE - Irlanda 31
FR - Francia 28
GB - Regno Unito 16
SG - Singapore 11
BE - Belgio 8
BZ - Belize 7
FI - Finlandia 6
CZ - Repubblica Ceca 5
IR - Iran 5
PL - Polonia 5
TR - Turchia 4
CH - Svizzera 3
CI - Costa d'Avorio 2
NL - Olanda 2
PH - Filippine 2
BR - Brasile 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
HU - Ungheria 1
RO - Romania 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.217
Città #
Chandler 150
Houston 42
Ashburn 41
Dublin 31
San Mateo 25
Jacksonville 23
Ann Arbor 22
San Jose 19
Nanjing 18
Dearborn 17
Wilmington 15
Princeton 12
Boston 11
Cattolica 11
New York 11
Beijing 10
Bremen 10
Milan 10
Woodbridge 10
Nürnberg 9
Brussels 8
Marseille 8
Albuquerque 7
Belize City 7
Fairfield 6
Hangzhou 6
Munich 6
Singapore 6
Andover 5
Lawrence 5
Los Angeles 5
Redwood City 5
Washington 5
Leawood 4
Nanchang 4
Rome 4
Chicago 3
Hebei 3
Izmir 3
Kunming 3
Las Vegas 3
Mountain View 3
Pune 3
Shenyang 3
Abidjan 2
Brno 2
Changsha 2
Crotone 2
Florence 2
Fremont 2
Kraków 2
Menlo Park 2
Paris 2
Remscheid 2
Saint Louis 2
San Diego 2
Shanghai 2
Zhengzhou 2
Amsterdam 1
Ardabil 1
Atlanta 1
Augusta 1
Baotou 1
Bari 1
Bern 1
Birmingham 1
Boardman 1
Brescia 1
Budapest 1
Buffalo 1
Changchun 1
Chengdu 1
Chiswick 1
Columbus 1
Duncan 1
Fondi 1
Fuzhou 1
Guangzhou 1
Helsinki 1
Istanbul 1
Jiaxing 1
Jinan 1
Jinhua 1
Johannesburg 1
Kemerovo 1
Kish 1
La Spezia 1
La Trinidad 1
Lanzhou 1
London 1
Madrid 1
Manila 1
Marcon 1
Mcallen 1
Nave 1
New Delhi 1
Phoenix 1
Phoenixville 1
Potenza 1
Redmond 1
Totale 682
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 204
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 164
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 122
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 94
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 94
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 79
Standardized data collection to build prediction models in oncology: A prototype for rectal cancer 74
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 67
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 57
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 52
Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial 50
Radiotherapy of prostate cancer: Impact of treatment characteristics on the incidence of second tumors 41
Radiation therapy for prostate cancer: What's the best in 2021 41
Radiotherapy plus GnRH analogue versus high dose bicalutamide: A case control study 38
BIT-ART: Multicentric comparison of HDR-brachytherapy, intensity-modulated radiotherapy and tomotherapy for advanced radiotherapy in prostate cancer 33
Simultaneous integrated radiotherapy boost to the dominant intraprostatic lesion: Final results of a phase I/II trial 29
Radiotherapy of prostate carcinoma: A comparison of the predictive role of EAU versus NCCN risk stratification systems 27
Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis 1
Totale 1.267
Categoria #
all - tutte 4.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.422


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201927 0 0 0 0 0 0 0 0 0 12 8 7
2019/2020202 24 3 10 7 21 19 13 6 21 6 51 21
2020/2021158 9 11 23 22 41 12 6 4 10 4 13 3
2021/2022156 11 8 4 8 12 8 5 24 9 11 32 24
2022/2023387 49 57 36 68 20 50 13 33 46 0 12 3
2023/2024139 10 49 7 13 6 29 7 7 5 6 0 0
Totale 1.267